Factors increasing hemorrhage risk in warfarin users
- Disopyramide and warfarin interaction. // British Medical Journal;10/1/1977, Vol. 2 Issue 6091, p866
Evaluates the implications of disopyramide and warfarin interaction. Presentation of a case of a marine engineer admitted to the coronary care unit; Absence of a reported interaction between disopyramide and warfarin in vivo; Effects of the displacement of warfarin by disopyramide.
- Serious interaction between warfarin and oral terbinafine. Warwick, J. A.; Corrall, R. J. // BMJ: British Medical Journal (International Edition);02/07/98, Vol. 316 Issue 7129, p440
Shows the drug interactions between warfarin and the oral antifungal terbinafine. Case of a sixty-eight year old woman who had taken warfarin medication for her mitral valve disease since 1973; Mechanism of action of warfarin; How terbinafine is excreted; Possible consequences of warfarin and...
- Combining antidepressants with warfarin. Deblinger, Larry // Patient Care for the Nurse Practitioner;Aug2001, Vol. 4 Issue 8, p11
Answers a question on which antidepressants present the highest risk of interacting with warfarin. Antidepressants that are least likely to interact with warfarin; Signs of increased anticoagulation; Mechanisms of drug interaction with warfarin.
- nimodipine. // Davis's Drug Guide for Nurses, 9th edition;2005, p757
Presents a guide for nurses on the administration of nimodipine, a subarachnoid hemorrhage therapy agent. Mechanism of action; Pharmacokinetics; Adverse reactions and side effects.
- Rol del factor VII recombinante activado en pacientes neuroquir�rgicos y neurocr�ticos. Rama-Maceiras, P.; Ingelmo-Ingelmo, I.; F�bregas-Juli�, N.; Hern�ndez-Palaz�n, J. // Revista Neurocirugia;jun2011, Vol. 22 Issue 3, p209
Central nervous system haemorrhage is a severe pathology, as a small amount of bleeding inside the brain can result in devastating consequences. Haemostatic agents might decrease the consequences of intracranial bleeding, whichever spontaneous, traumatic, or anticoagulation treatment etiology....
- Research & Markets: Polypoidal Choroidal Vasculopathy -- Pipeline Review, H2 2011. // Biomedical Market Newsletter;12/21/2011, Vol. 21, p1
The article informs that Research & Markets Ltd. has announced the inclusion of the business analyst Global Markets Direct's new report "Polypoidal Choroidal Vasculopathy: Pipeline Review, H2 2011" to their offering. It provides an overview of the Polypoidal Choroidal Vasculopathy (PCV)...
- Risk of Major Hemorrhage for Outpatients Treated with Warfarin. McMahan, Deborah A.; Smith, David M.; Carey, Mark A.; Zhou, Xiao Hua; McMahan // JGIM: Journal of General Internal Medicine;May1998, Vol. 13 Issue 5, p311
OBJECTIVE:To determine the incidence of major hemorrhage among outpatients started on warfarin therapy after the recommendation in 1986 for reduced-intensity anticoagulation therapy was made, and to identify baseline patient characteristics that predict those patients who will have a major...
- Pharmacists' involvement in warfarin therapy reduced total bleeding by half. Cona, Christen; Harris, Jason; Southall, Jennifer // Hem/Onc Today;10/25/2010, Vol. 11 Issue 20, p27
The article discusses research being done on the effectiveness of pharmacist-participated warfarin treatment in reducing total bleeding, which references a study by Surasak Saokaer and colleagues in a 2010 issue of the "Journal of Thrombosis and Haemostasis."
- Coffee Mystery Solved. // Food Engineering & Ingredients;Oct2002, Vol. 27 Issue 5, p26
Reports on the mechanism responsible for the caffeine kick in coffee products in Sweden. Effect of drinking few cups of coffee in one day; Immunity of mice to the stimulatory impact of coffee.